Literature DB >> 17949468

Concurrent dietary administration of D-SAL and ethanol diminishes ethanol's teratogenesis.

Scott E Parnell1, Shao-yu Chen, Michael E Charness, Clyde W Hodge, Deborah B Dehart, Kathleen K Sulik.   

Abstract

BACKGROUND: SAL (SALLRSIPA) is a peptide fragment of activity-dependent neurotrophic factor. Both L- and D-SAL diminish ethanol's pathogenesis, however, the D-peptide is protease resistant, and can therefore be effectively administered in a diet. The present study tested the hypothesis that D-SAL provided in a liquid diet containing ethanol will prevent ethanol-induced teratogenicity in mice.
METHODS: Following an ethanol acclimation period, female C57Bl/6J mice were withdrawn from the ethanol, bred, and then returned during gestational days (GD) 7 and 8 to a control liquid diet or one containing 4.8% ethanol alone or in combination with 5.6 microg/ml D-SAL. At these doses, the mice received approximately 75 microg of D-SAL on each day and achieved peak blood-alcohol concentrations on GD 8 that ranged from 148-162 mg/dl. On GD 14, the fetuses were examined for the presence of ocular abnormalities including microphthalmia and irregularly shaped pupils, teratogenic effects known to result from this ethanol exposure paradigm.
RESULTS: Dietary D-SAL reduced the incidence of ocular defects in ethanol-exposed fetuses from 29 to 10% in the right eyes and from 21 to 7.5% in the left eyes; levels similar to those observed in pair-fed controls. In addition to decreasing their incidence, D-SAL also reduced the severity of the ocular defects.
CONCLUSIONS: These results demonstrate that oral D-SAL can prevent ethanol-induced ocular defects. Because ocular defects are commonly associated with CNS damage, oral D-SAL may also prove valuable in preventing ethanol-induced brain defects.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17949468     DOI: 10.1111/j.1530-0277.2007.00524.x

Source DB:  PubMed          Journal:  Alcohol Clin Exp Res        ISSN: 0145-6008            Impact factor:   3.455


  13 in total

Review 1.  From research to practice: an integrative framework for the development of interventions for children with fetal alcohol spectrum disorders.

Authors:  Piyadasa W Kodituwakku; E Louise Kodituwakku
Journal:  Neuropsychol Rev       Date:  2011-05-06       Impact factor: 7.444

Review 2.  Magnetic resonance-based imaging in animal models of fetal alcohol spectrum disorder.

Authors:  Shonagh K O'Leary-Moore; Scott E Parnell; Robert J Lipinski; Kathleen K Sulik
Journal:  Neuropsychol Rev       Date:  2011-03-29       Impact factor: 7.444

3.  Two alcohol binding residues interact across a domain interface of the L1 neural cell adhesion molecule and regulate cell adhesion.

Authors:  Xiaowei Dou; Carrie E Menkari; Sivananthaperumal Shanmugasundararaj; Keith W Miller; Michael E Charness
Journal:  J Biol Chem       Date:  2011-03-02       Impact factor: 5.157

4.  Disruption of social approach by MK-801, amphetamine, and fluoxetine in adolescent C57BL/6J mice.

Authors:  Sheryl S Moy; Randal J Nonneman; Geoffrey O Shafer; Viktoriya D Nikolova; Natallia V Riddick; Kara L Agster; Lorinda K Baker; Darin J Knapp
Journal:  Neurotoxicol Teratol       Date:  2012-08-07       Impact factor: 3.763

5.  Reduction of ethanol-induced ocular abnormalities in mice through dietary administration of N-acetylcysteine.

Authors:  Scott E Parnell; Kathleen K Sulik; Deborah B Dehart; Shao-yu Chen
Journal:  Alcohol       Date:  2010-06-18       Impact factor: 2.405

6.  Activity-dependent neurotrophic factor-derived peptide prevents alcohol-induced apoptosis, in part, through Bcl2 and c-Jun N-terminal kinase signaling pathways in fetal brain of C57BL/6 mouse.

Authors:  Y Sari; J M Weedman; S Ge
Journal:  Neuroscience       Date:  2011-12-06       Impact factor: 3.590

7.  Peptidergic agonists of activity-dependent neurotrophic factor protect against prenatal alcohol-induced neural tube defects and serotonin neuron loss.

Authors:  Feng C Zhou; Yuan Fang; Charles Goodlett
Journal:  Alcohol Clin Exp Res       Date:  2008-06-28       Impact factor: 3.455

8.  Neurotrophic peptides, ADNF-9 and NAP, prevent alcohol-induced apoptosis at midgestation in fetal brains of C57BL/6 mouse.

Authors:  Youssef Sari; Jason M Weedman; Maxwell Nkrumah-Abrokwah
Journal:  J Mol Neurosci       Date:  2012-11-16       Impact factor: 3.444

Review 9.  Ethanol's molecular targets.

Authors:  R Adron Harris; James R Trudell; S John Mihic
Journal:  Sci Signal       Date:  2008-07-15       Impact factor: 8.192

10.  D-SAL and NAP: Two Peptides Sharing a SIP Domain.

Authors:  Illana Gozes; Shlomo Sragovich; Yulie Schirer; Anat Idan-Feldman
Journal:  J Mol Neurosci       Date:  2016-06       Impact factor: 3.444

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.